trustmebro.to/r/…
✓ checked
trust me, bro:
here is the receipt.
the claim

Excessive glucose levels cause cellular damage through oxidative stress and glycation.

the verdict
SUPPORTED
the evidence backs this
Recorded sources
5 sources for · 0 against

Counts group repeated records of the same source within each side. They do not measure evidence strength or source independence.

Is it true that excessive glucose levels cause cellular damage through oxidative stress and glycation?

Yes. Multiple studies substantiate that excessive glucose levels drive cellular damage via oxidative stress and the accumulation of advanced glycation end products (AGEs).

Verdict: SUPPORTED · 5 sources for, 0 against · Last checked

The analysis

The retrieved literature consistently supports the mechanistic link between excess glucose (hyperglycemia), the formation of advanced glycation end products (AGEs), the induction of oxidative stress (ROS generation), and subsequent cellular damage across various tissue types. None of the papers refute this foundational concept.

Evidence for · 5
2024
Demonstrates that advanced glycation end products (AGEs) derived from glucose toxicity induce intracellular reactive oxygen species (ROS) and cellular damage/pyroptosis.
Get citation
Liu, D., Mei, X., Mao, Y., Li, Y., Wang, L., & Cao, X. (2024). Lentinus edodes mycelium polysaccharide inhibits AGEs-induced HUVECs pyroptosis by regulating LncRNA MALAT1/miR-199b/mTOR axis and NLRP3/Caspase-1/GSDMD pathway.. doi.org. https://doi.org/10.1016/j.ijbiomac.2024.131387

See more details
More for · 4
2026
Details how chronic hyperglycemia drives severe microvascular and macrovascular complications through the reciprocal interaction of elevated glucose and ROS-induced oxidative stress.
Get citation
EE, Y., YA, A., Y, B., & Z, H. (2026). The vicious cycle of hyperglycemia and oxidative stress: Novel mechanistic insights into a pathogenic alliance.. doi.org. https://doi.org/10.1016/j.biocel.2026.106990

2026
Explains that hyperglycemia and lipotoxicity trigger redox imbalance and drive the formation of advanced glycation end products (AGEs) which sequester antioxidants and promote inflammation.
Get citation
CA, U., T, S., V, S., & J, A. (2026). Redox Imbalance in Gestational Diabetes Mellitus: Mechanistic Insights, Emerging Biomarkers, and Therapeutic Perspectives.. doi.org. https://doi.org/10.3390/ijms27114755

2026
Highlights how persistent hyperglycemia initiates oxidative stress and the accumulation of advanced glycation end products (AGEs), disrupting cellular bioenergetic homeostasis.
Get citation
Y, C., J, X., Y, Y., & HB, S. (2026). Reactivating mitochondrial quality control via the Nrf2 pathway to combat metabolic stress in diabetic osteoarthritis.. doi.org. https://doi.org/10.1016/j.cellsig.2026.112545

2026
Discusses how nonenzymatic glycation generates advanced glycation end products (AGEs) that alter protein function and act through receptors to initiate oxidative stress, inflammation, and tissue remodeling.
Get citation
S, K., R, S., & V, K. (2026). Glycation at the Crossroads of Disease Pathogenesis: Mechanistic Insights and Therapeutic Frontiers.. doi.org. https://doi.org/10.3390/diseases14040137

Related receipts

What does the evidence say?

The retrieved literature consistently supports the mechanistic link between excess glucose (hyperglycemia), the formation of advanced glycation end products (AGEs), the induction of oxidative stress (ROS generation), and subsequent cellular damage across various tissue types. None of the papers refute this foundational concept.

Receipt History
first checked04 Aug 2026
judged → SUPPORTED · 8204 Aug 2026
Anyone with this link can read the claim and its public receipt, including any personal information in that text. Open permanent receipt.
Check your own claim
Challenge the receipt
Requests are recorded for review. This does not start an automatic check or guarantee a response time.

See the evidence timeline

Citation formatting by citeproc-js (Frank Bennett) and the Citation Style Language project. Source and licenses.

This receipt is an automated verdict against our published method · not an opinion about any author or publication.
Terms · Privacy · How verdicts work